V
Viridian Therapeutics, Inc. (VRDN)
NCM – Real vaqt narxi. Valyuta: USD
16.86
-0.34 (-1.98%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
16.86
-0.34 (-1.98%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Viridian Therapeutics, Inc. jiddiy va kam uchraydigan kasalliklarni davolash usullarini kashf etish, ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Kompaniya qalqonsimon bez kasalligi (TED)ni davolash uchun IGF-1R terapiyasini ishlab chiqadi, shu jumladan Veligrotrug, IV yuboriladigan IGF-1R ga yo'naltirilgan differentsiallashtirilgan insonlashtirilgan monoklonal antitel, va Elegrobart, kam hajmli, kamdan-kam yuboriladigan teri osti IGF-1R. Kompaniya, shuningdek, Graves kasalligi va TEDni davolash uchun qalqonsimon bezni stimulyatsiya qiluvchi gormon retseptoriga (TSHR) qarshi nomzodni ishlab chiqadi. Neonatal Fc retseptorining (FcRn) muhandislik inhibitorlari portfeliga VRDN-006, yuqori selektiv Fc fragmenti, va VRDN-008, GC fragmenti va IGGni bostirishni uzaytirish uchun mo'ljallangan albumin bog'lanish domenidan iborat yarim umri uzaytirilgan bispesifik FcRn inhibitori kiradi. Kompaniya ilgari Miragen Therapeutics, Inc. nomi bilan tanilgan va 2021 yil yanvar oyida Viridian Therapeutics, Inc. nomini o'zgartirgan. Viridian Therapeutics, Inc. 2010 yilda tashkil etilgan va shtab-kvartirasi Uoltam, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Eric N. Olson Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
| Dr. Marvin H. Caruthers Ph.D. | Co-Founder & Scientific Advisory Board Member |
| Dr. Michael R. Bristow M.D., Ph.D. | Co-Founder & Member of the Scientific Advisory Board |
| Dr. Radhika Tripuraneni M.D., M.P.H. | Chief Medical Officer |
| Mr. Seth Harmon | Chief Financial Officer |
| Mr. Stephen F. Mahoney J.D., MBA | CEO, President & Director |
| Mr. Thomas W. Beetham J.D., MBA | Chief Operating Officer |
| Mr. Vahe Bedian Ph.D. | Co-Founder & Scientific Advisor |
| Ms. Jennifer Tousignant J.D. | Chief Legal Officer & Corporate Secretary |
| Ms. Melissa Manno | Chief Human Resources Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-11 | 8-K | d154062d8k.htm |
| 2026-05-07 | 305B2 | d161096d305b2.htm |
| 2026-05-05 | 8-K | d20977d8k.htm |
| 2026-04-17 | DEFA14A | d904274ddefa14a.htm |
| 2026-03-30 | 8-K | d27955d8k.htm |
| 2026-02-26 | S-8 | d62671ds8.htm |
| 2026-02-26 | 10-K | vrdn-20251231.htm |
| 2025-11-05 | 8-K | d33707d8k.htm |
| 2025-11-05 | 10-Q | vrdn-20250930.htm |
| 2025-10-23 | 8-K | d27166d8k.htm |